Press release
Immunotherapy Drugs Market In-Depth Overview of Product Specification, Technology - P&S Intelligence
immunotherapy drugs
Checkpoint inhibitors and vaccines are the two major types of immunotherapy drugs analyzed in the report. Of these, checkpoint inhibitors held a larger share in the immunotherapy drugs market, accounting for 66.3% in 2017. Checkpoint inhibitors are the first preference for the treatment of chronic diseases, as they provide better and effective treatment results. These drugs act directly on site of action, without delaying the effect of medicine, and are thus being highly adopted for the treatment of several diseases. Some of the major checkpoint inhibitors brand available in the market are Humira, Rituxan/MabThera, Herceptin, Remicade, and Enbrel.
Access Detailed Report Summary at: https://www.psmarketresearch.com/market-analysis/immunotherapy-drugs-market
Globally, the rising prevalence of chronic diseases is a major healthcare burden that effects high income nations as well as low and middle-income countries (LMIC). The impact of these diseases can be ascertained from the fact that cancer is estimated to lead to 9.6 million deaths in 2018, as reported by the World Health Organisation (WHO). The organisation further stated that around 70% of deaths from cancer occur in LMIC.
Download Report Sample at: https://www.psmarketresearch.com/market-analysis/immunotherapy-drugs-market/report-sample
The report provides epidemiology analysis for cancer, autoimmune and inflammatory diseases, and infectious diseases. According to the International Agency for Research on Cancer (IARC) in 2018, 18.1 million people are estimated to be suffering from cancer globally, which is expected to reach 29.5 million by 2040. Another study conducted by the American Medical Association (AMA) between 2005–2015, reported that the incident of cancer cases increased by 33% during this period, of which 16.4% of the cases were due to aging population.
Make Enquiry Before Buying the Report: https://www.psmarketresearch.com/send-enquiry?enquiry-url=immunotherapy-drugs-market
The market players in the immunotherapy drugs market are actively seeking collaborations and partnerships for the development of novel immunotherapy drugs. For instance, in April 2018, Bristol-Myers Squibb Company (BMS) and Illumina Inc. collaborated to utilize Illumina’s next-generation sequencing (NGS) technology to develop and globally commercialize in-vitro diagnostic (IVD) assays in support of BMS oncology portfolio. The collaboration helped to develop a diagnostic version of Illumina’s TruSight Oncology 500 assay, including tumor mutation burden (TMB), and microsatellite instability for immunotherapies.
Some of the other leading players operating in the global immunotherapy drugs market are F. Hoffmann-La Roche Ltd., AbbVie Inc., AstraZeneca PLC, Merck & Co. Inc., GlaxoSmithKline plc, Novartis International AG, Johnson & Johnson, Amgen Inc., Bristol-Myers Squibb Company, Eli Lilly and Company, Sanofi, Medigene AG, C. H. Boehringer Sohn AG & Co. KG, Takeda Pharmaceutical Company Limited, and Celgene Corporation.
About P&S Intelligence
P&S Intelligence is a provider of market research and consulting services catering to the market information needs of burgeoning industries across the world. Providing the plinth of market intelligence, P&S as an enterprising research and consulting company, believes in providing thorough landscape analyses on the ever-changing market scenario, to empower companies to make informed decisions and base their business strategies with astuteness.
Contact:
P&S Intelligence
Toll-free: +1-888-778-7886 (USA/Canada)
International: +1-347-960-6455
Email: enquiry@psmarketresearch.com
Web: https://www.psmarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Immunotherapy Drugs Market In-Depth Overview of Product Specification, Technology - P&S Intelligence here
News-ID: 1745740 • Views: …
More Releases from P&S Intelligence
U.S. ESG Investments Market Set to Skyrocket: $16 Trillion by 2032
According to the latest market research study published by P&S Intelligence, the U.S. Environmental, Social, and Governance (ESG) investments market is experiencing a significant surge, with projections indicating an increase from $6.5 trillion in 2024 to an estimated $16.0 trillion by 2032. This represents a robust compound annual growth rate (CAGR) of 12.1% over the forecast period.
According to a comprehensive analysis by P&S Intelligence, the market's expansion is driven…
Facility Management in the U.K. Booms with 14.1% CAGR as Demand Soars Across Sec …
According to the latest market research study published by P&S Intelligence, the U.K. facility management market is poised for significant growth, with projected revenues reaching USD 2,743.3 million in 2024 and expected to soar to USD 6,038.4 million by 2030, reflecting a robust CAGR of 14.1% during the forecast period.
This expansion is fueled by a surge in demand across both public and private sectors. According to the RICS U.K.…
Point-of-Sale Software Market in the U.S. Set to Grow by 9.7% CAGR, Boosted by O …
According to the latest market research study published by P&S Intelligence, the U.S. point-of-sale (POS) software market, valued at USD 4.7 billion in 2024, is poised for significant growth over the coming years, with projections estimating it will reach USD 9.8 billion by 2032, expanding at a compound annual growth rate (CAGR) of 9.7%. This growth is attributed to rapid technological advancements, a surge in mobile and cloud-based POS systems,…
Competitive Landscape of the Industrial Starches Market: Key Players, Trends, an …
According to the latest market research study published by P&S Intelligence, the global industrial starches market is poised for significant growth, with a projected increase from USD 110.3 billion in 2024 to USD 169.9 billion by 2030, at a robust compound annual growth rate (CAGR) of 7.5%. Industrial starches play a crucial role in diverse sectors, including food, pharmaceuticals, and paper, driven by their unique properties such as stabilizing, thickening,…
More Releases for International
XINHUA NET: EPWK Launches International Business Expansion, Debuts English Versi …
On June 9, 2025, Xinhua Net, under the headline "EPWK Launches International Business Expansion, Debuts English Version of International Website," [https://www.news.cn/digital/20250609/b64a2bd0e54e4c8d86320faf34c010a2/c.html] reported on EPWK's accelerated push into the global market. The specific content of the report is as followed:
Image: https://www.globalnewslines.com/uploads/2025/06/4f351787425f036e669eb3e10b060bb5.jpg
Photo: Report on Xinhua Net
Recently, EPWK (stock code: EPWK), a Nasdaq-listed company, officially launched its international business expansion with the debut of the English version of its international website (intl.epwk.com). This…
Quillaia Extract Market Statistical Forecast, Trade Analysis 2024 - Garuda Inter …
DataM Intelligence has published a new research report on "Quillaia Extract Market Size 2024". The report explores comprehensive and insightful Information about various key factors like Regional Growth, Segmentation, CAGR, Business Revenue Status of Top Key Players and Drivers. The purpose of this report is to provide a telescopic view of the current market size by value and volume, opportunities, and development status.
Get a Free Sample Research PDF -…
United Kingdom Sotheby’s International Realty focuses on international relatio …
United Kingdom Sotheby's International Realty is continuing its recruitment drive with the appointment of Christine Petersen as Head of Referrals and International Relocation.
In a newly created role Christine will work with a global network of more than 500 Sotheby's International Realty offices, which operate in 44 countries, to provide all-round property expertise both domestically and internationally.
Charles Smith, Managing Director of United Kingdom Sotheby's International Realty, said: "The UK property market…
International agreement on the FAIR international accelerator facility
Today in Wiesbaden, Germany, nine countries signed the international agreement on the construction of the accelerator facility FAIR (Facility for Antiproton and Ion Research), which will be located at the GSI Helmholtz Center for Heavy Ion Research in Darmstadt, Germany. Signing the agreement for Germany were Helge Braun, Parliamentary State Secretary to the Federal Minister for Education and Research, and Peter Ammon, State Secretary of the Federal Foreign Office. Also…
Manthan International School offers new Cambridge International Primary Programm …
Membership of Cambridge International Primary Programme, approved for local school.
Manthan International School has been awarded membership of the Cambridge International Primary Programme by University of Cambridge International Examinations (CIE).
Manthan International School will be able to use the Cambridge International Primary Programme, which helps teachers develop Mathematics, English and Science skills and knowledge in children aged five to eleven. The Cambridge International Primary Programme provides guidance for curriculum…
Lotier International and Demtech International sign a cooperation agreement
LOTIER (Brazil) forms a strategic alliance with Demtech (Spain) to provide direct sales and market access to Southern Europe for Lotier clients and to provide Latin America, Asian and Middle East market access to Demtech clients.
Sao Paulo, Brazil (September 14th, 2010) –
LOTIER international, a multinational business developement company for high-tech and telecom products and services in high-growth markets, announced today a formal partnership with Demtech Inc,…
